3Chang LC,Haggstrom AN,Drolet BA,et al.Growth characteristics of infantile hemangiomas:implications for management[J].Pediatrics,2008,122:360-367.
4Bruckner AL,Frieden U.Hemangiomas of infancy[J].J Am Acad Dermatol,2003,48:477-493.
5Walter JW,North PE,Waner M,et al.Somatic mutation of vascular endothelial growth factor receptors in juvenile hemangioma[J].Genes Chromosomes Cancer,2002,33:295-303.
6Berg JN,Walter JW,Thisanagayam U,et al.Evidence for loss of heterozygosity of 5q in sporadic haemangiomas:are somatic mutations involved in haemangioma formation[J]? J Clin Pathol,2001,54:249-252.
7Ritter MR,Moreno SK,Dorrell MI,et al.Identifying potential regulators of infantile hemangioma progression through large-scale expression analysis:a possible role for the immune system and indoleamine 2,3 dioxygenase(IDO)during involution[J].Lymphat Res Biol,2003,1:291-299.
8Ritter MR,Dorrell MI,Edmonds J,et al.Insulin-like growth factor 2 and potential regulators of hemangioma growth and involution identified by large-scale expression analysis[J].Proc Natl Acad Sci USA,2002,99:7455-7460.
9Barnes CM,Huang S,Kaipainen A,et al.Evidence by molecular profiling for a placental orion of infantile hemangioma[J].Proc Natl Acad Sci USA,2005,102:19097-19102.
10Pittman KM,Losken HW,Kleinman ME,et al.No evidence for matemal-fetal microchimerism in infantile hemangioma:a molecular genetic investigation[J].J Invest Dermatol,2006,126:2533-2538.
9Chao YH, I.iang IX;, Chen SH, etal Interferon-alpha for a larming hemangiomas in infants: experience of a single institution [J] Pediatr Int, 2009, 51 (4): 469-473.
10Xu ZQ, Liu Y, Wang YX, et al. Therapeutic effects of Avastin on the murine hemangioendothelioma [J]. Beijing Da Xue XueBao, 2009, 41 (1): 105-108.